Clinical Trial
Augmented Reality BCI Longitudinal Study for Persons With Late Stage ALS
ClinicalTrials.gov6/1/2025·06/01/25🌐 USA
Summary
This longitudinal study provides Cognixion's AXON-R headset combining augmented reality, BCI, and AI to late-stage ALS patients for at-home use over 6 months. The system enables hands-free communication and computing control using brain-computer interface technology integrated with an AR display.
Why it matters
Late-stage ALS patients often lose all means of communication. Cognixion's non-invasive AR-BCI system could restore communication and digital independence without surgery, offering hope to patients who are not candidates for implanted BCI devices.
#BCI#ALS#Wearables#Non-invasive#AI#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in